COCP
Cocrystal Pharma, Inc. Common Stock
stockNASDAQ
cocrystal (otcqb:cocp) is a pharmaceutical company seeking to discover novel antiviral therapeutics as treatments for serious and/or chronic viral diseases. cocrystal employs unique technologies and nobel prize winning expertise to create first- and best-in-class antiviral drugs. these technologies, including our nucleoside chemistry expertise and market-focused approach to drug discovery are designed to efficiently deliver small molecule therapeutics that are safe, effective and convenient to administer. the company has identified promising, preclinical stage antiviral compounds for the unmet medical needs including hepatitis, influenza and norovirus infections. cocrystal has previously received strategic investments from teva pharmaceuticals, opko health (opk), dr. raymond schinazi, brace pharmaceutical, llc, and the frost group.
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 1.21 | 2026-09-28 | -4.13% | 2.862 |
| 1M | 1.13 | 2026-09-04 | +2.65% | -0.447 |
| 3M | 1.04 | 2026-07-06 | +11.54% | 1.540 |
| 6M | 1.50 | 2026-04-06 | -22.67% | 1.319 |
| 1Y | 1.21 | 2025-10-03 | -4.13% | 1.572 |
| 2Y | 1.83 | 2024-10-04 | -36.44% | — |
| 5Y | 12.00 | 2021-10-04 | -90.33% | 0.678 |
Cocrystal Pharma, Inc. Common Stock (NASDAQ:COCP) stock price today is $1.16, and today's volume is 13,714. COCP is up 1.754% today. The 30 day average volume is 51,074. COCP market cap is $22.35M with 19.26M shares outstanding.